Neil Wolff

General Counsel & MD at VantagePoint Management, Inc.

Neil Wolff

Neil Wolff

General Counsel & MD at VantagePoint Management, Inc.

Biography

With thousands of completed transactions during his 30+ year legal career, Neil has provided an experienced perspective as an advisor for the Firm’s investments as well as to its portfolio companies since he became VantagePoint’s General Counsel in 2006. Neil was one of VantagePoint’s key outside attorneys when he was a partner at Wilson Sonsini Goodrich & Rosati, which he joined in 1984. While at Wilson Sonsini he represented a number of VantagePoint portfolio companies. Neil is a graduate of Oxford University (MBA) and UCLA School of Law (JD).

Overview
Career Highlights

VantagePoint Management, Inc.

RelSci Relationships

763

Relationships
RelSci Relationships are individuals Neil Wolff likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at VantagePoint Management, Inc.

Relationship likelihood: Strong

Co-Founder & Managing Director at VantagePoint Management, Inc.

Relationship likelihood: Strong

Founder at Greenbridge Partners LLC

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Vionx Energy corp.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at UGSI Solutions, Inc.

Relationship likelihood: Strong

Founder at William McDonough + Partners LLC

Relationship likelihood: Strong

Former Chief Investment Officer at BP Group Plc

Relationship likelihood: Strong

Chief Operating Officer & Managing Director at VantagePoint Management, Inc.

Relationship likelihood: Strong

Partner at VantagePoint Management, Inc.

Relationship likelihood: Strong

Managing Partner at New Energy Capital Partners LLC

Relationship likelihood: Strong

Paths to Neil Wolff
Potential Connections via
Relationship Science
You
Neil Wolff
General Counsel & MD at VantagePoint Management, Inc.
Education
BA

The University of Florida (commonly referred to as Florida or UF) is an American public land-grant, sea-grant, and space-grant research university located on a 2,000-acre (8.1 km2) campus in Gainesville, Florida. It is a senior member of the State University System of Florida and traces its historical origins to 1853, and has operated continuously on its present Gainesville campus since September 1906. The University of Florida is ranked 14th overall among all public national universities in the 2014 U.S. News & World Report rankings, and has ranked within the top 100 universities worldwide. The University of Florida was also described as a "Public Ivy" in the book The Public Ivies: America's Flagship Public Universities.

JD

UCLA School of Law is the youngest top law school in the nation. After more than 60 years, our school has never felt bound by outmoded ideas of how law should be taught or studied. Instead, beginning in the 1950s, UCLA created its own tradition - a tradition of innovation.

MBA

Saïd Business School (SBS) is the business school of the University of Oxford in England. It is the University of Oxford's centre of learning for graduate and undergraduate students in business, management and finance. Established in 1996, Saïd Business School is a relatively new business school. It is named after Wafic Saïd, a Saudi-Syrian billionaire and chief founding benefactor, having donated £70 million to date.[2] The current dean is Peter Tufano, who was formerly on the faculty of the Harvard Business School for 22 years.

Graduate Unknown

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Career History
General Counsel & MD
2006 - Current

VantagePoint Management focuses on investments in the clean technology, information technology and healthcare sectors. Within the clean technology sector, the firm invests mainly in the solar, transportation, energy storage and power management, smart grid, biofuels and water sectors. Within information technology, they tend to invest in the financial technology, Internet/digital media, enterprise solutions and mobile/wireless sectors. VantagePoint healthcare investment include including biotechnology, medical devices and healthcare commerce. In addition, the firm invests in Asia in the clean technology, consumer, healthcare and TMT (technology, media and telecommunications) sectors. Vantage Point invests across a variety of phases of development from start-up through scale-up.

Professional
1987 - 1988

Nagashima Ohno & Tsunematsu is widely known as a leading law firm and the foremost provider of international and commercial legal services in Japan. They represent domestic and foreign companies and organizations involved in every major industry sector and in every legal service area in Japan.

Research Department Employee
Prior

Tekla Capital Management LLC is the investment adviser for four closed-end equity funds: Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Health Care Opportunities Fund and Tekla World Healthcare Fund. The funds invest in public and private growth equities in the healthcare and life sciences industries.Tekla Healthcare Investors (HQH) is a broadly diversified closed-end healthcare fund that invests primarily in biotechnology, medical devices and pharmaceuticals. The fund seeks to provide long-term capital appreciation through investments in companies in the health technology industries that have the potential for above-average long-term growth. The fund focuses on smaller, emerging companies with no more than 40% of its assets invested in the restricted securities of public and private companies. The fund is somewhat larger than Tekla Sciences Investors.Tekla Life Sciences Investors (HQL) is a broadly diversified closed-end healthcare fund that invests primarily in biotechnology, medical devices and pharmaceuticals. The fund seeks to provide long-term capital appreciation through investments in companies in the health technology industries that have the potential for above-average long-term growth. The fund is more focused on life science technology than Tekla Healthcare Investors, expanding the biotechnology focus to include investments in agricultural biotechnology and environmental technology, focusing on smaller, emerging companies with no more than 40% of its assets invested in the restricted securities of public and private companies. Both funds invest in small, emerging growth companies but Tekla Life Science's holdings tend to be somewhat smaller and slightly more volatile.Tekla Healthcare World Fund (TWH) is a non-diversified closed-end fund that invests primarily in the healthcare industry. The Fund's objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles.Tekla Healthcare Opportunities Fund (THQ) is a non-diversified closed-end fund that seeks current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles.

Transactions
Details Hidden

Microsemi Storage Solutions, Inc. purchases PMC-Sierra Israel Ltd.

Details Hidden

Microsemi Storage Solutions, Inc. purchases Agilent Technologies, Inc. /Storage Semiconductor Bus from Agilent Technologies, Inc., Silver Lake Partners LP, Kohlberg Kravis Roberts & Co. LP

Details Hidden

PeoplePC, Inc. issued USD Common Stock

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Neil Wolff. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Neil Wolff's profile does not indicate a business or promotional relationship of any kind between RelSci and Neil Wolff.